Editorials

The two forms of adrenocortical nodular disease (PPNAD and BMAD) have different aetiologies that demand distinct treatment approaches – understanding their respective cause can also lead to a personalized approach to care. Read on to discover more.

Read on to see what the Editorial Board says about Cushing’s syndrome in different age groups, particularly the recent study that shows differences in presentation between younger patients and those aged 65 years or above.

Read about the latest joint clinical guidelines from the European Society of Endocrinology and the Endocrine Society in this spring editorial.

This editorial looks at the impact of different adrenal hormone subtypes on frailty in patients with adrenal adenomas – is ‘NFAT’ the correct term?

This editorial discusses the recent changes to the ESE/ENSAT joint guidelines and invites you to attend the 2023 Cushing’s Hub webinar – Explore Real-World Clinical Scenarios in Mild Autonomous Cortisol Secretion (MACS)

This editorial looks at the emerging importance of inflammation-based scores in tumour development and progression, as well as prognosis.

Cushing’s Hub warmly welcomes the new Editorial Board – read on to see what the team have to say about their new role.

This editorial looks at the value of technology in medical education, in particular the webinar, as a context for the launch of the EACCME® Accredited Cushing's Hub Webinar Series.

This editorial looks at the challenges associated with rare disease recognition with regard to all health care professionals who encounter Cushing’s patients.

October is Pituitary Awareness Month when patients, carers and healthcare professionals seek to raise awareness of the importance of the pituitary gland in the onset of disease.

Another year of Cushing’s syndrome! Some challenges have been overcome and some persist

The editorial introduces the latest content on Cushing's Hub and explains the background to the exciting new Cushing's Hub Competition!

This editorial highlights the new Conference area on Cushing’s Hub which enables users to visualise the international conference calendar ‘at a glance’ – societies, dates, and localities. Relevant aspects of the immediate conferences are provided as well as ‘cut off dates’ for ‘early bird’ registrations.

This editorial recaps on the achievements of Cushing’s Hub to date and highlights the latest additions to the content which include an exploration of the common complications of Cushing’s syndrome (see Varlamov EV, et al. Animated Abstract); the exciting advances in our understanding of the genetic basis of GIP-dependent PBMAH (see Chasseloup, et al. Publication Highlight); and the forthcoming Interactive Clinical Case by Dr Niki Karavitaki on the challenges of identifying Cushing’s patients.

Nelson’s syndrome (NS), or corticotroph tumour progression (CTP) after bilateral adrenalectomy (BADX) for Cushing’s disease, can be a challenging condition to manage. This editorial explores the recent expert consensus recommendations (Reincke et al. Eur J Endocrinol. 2021; 184(3):P1–P16) which encompass surveillance criteria, surgical approaches, and use of radiation therapy, as well as a change in terminology.

This editorial looks at highly important yet non-routine aspects of Cushing’s syndrome and encourages readers to consider elements of the disease where literature is scarce.  Topics include once-in-a-lifetime events necessitating hospitalization – sometimes before diagnosis is made – and practical advice on the use of steroidogenesis inhibitors. The editorial also highlights recent research on the effect of Cushing’s syndrome on pregnancy outcomes.

A website on Cushing’s syndrome? Why would I be interested in a website like that?

The Editorial Board Members describe the importance of a website dedicated to Cushing’s syndrome and the reasons they signed up for the project